Novo Nordisk Acquires Ziylo in Possible $800 Million-Plus Deal
Copenhagen, Denmark-based Novo Nordisk acquired Bristol, UK-based Ziylo in a deal that could exceed $800 million.
The Home of the Life Sciences Industry
Explore Latest News
Teva Snags FDA Approval for Generic EpiPen
Shares of Teva Pharmaceuticals jumped more than 7 percent in afternoon trading Thursday and continue to rise in premarket trading this morning after the U.S. Food and Drug Administration approved the company’s generic version of the EpiPen Auto-Injector.
- Updated: Iovance Continues Path in Developing TIL Treatments for Solid Tumors
- Antiva Biosciences: Case Study in Difficulties Facing Biotechs Focused on Women’s Health
- August 17 Research Roundup: Glaucoma, Lung Cancer, Migraines and Spaghetti
- Bay State is Home to Four Biotech Unicorns
- You Never Have a Second Chance to Make a Good First Impression!
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.